Cargando…
Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection
Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of usin...
Autores principales: | Takenouchi, T., Iwasaki, Y.W., Harada, S., Ishizu, H., Uwamino, Y., Uno, S., Osada, A., Abe, K., Hasegawa, N., Murata, M., Takebayashi, T., Fukunaga, K., Saya, H., Kitagawa, Y., Amagai, M., Siomi, H., Kosaki, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585492/ https://www.ncbi.nlm.nih.gov/pubmed/34756867 http://dx.doi.org/10.1016/j.jhin.2020.10.014 |
Ejemplares similares
-
Pro108Ser mutation of SARS-CoV-2 3CL(pro) reduces the enzyme activity and ameliorates the clinical severity of COVID-19
por: Abe, Kodai, et al.
Publicado: (2022) -
Control of a Nosocomial Outbreak of COVID-19 in a University Hospital
por: Harada, Sei, et al.
Publicado: (2020) -
Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan
por: Uchida, Sho, et al.
Publicado: (2021) -
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan
por: Nishimura, Tomoyasu, et al.
Publicado: (2021) -
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals
por: Uwamino, Yoshifumi, et al.
Publicado: (2022)